A R Haug1, G Assmann, C Rist, R Tiling, G P Schmidt, P Bartenstein, M Hacker. 1. Klinik und Poliklinik für Nuklearmedizin, Klinikum der Ludwigs-Maximilians-Universität München, Campus Grosshadern, Marchioninistr. 15, 81377, München, Deutschland. Alexander.Haug@med.uni-muenchen.de
Abstract
PURPOSE: The immunohistochemical expression of somatostatin receptor (SSTR) subtype 2 was compared to quantitative (68)Ga-DOTATATE PET in neuroendocrine tumors (NET). MATERIAL AND METHODS: In 27 patients suffering from metastatic NET the expression of somatostatin receptors (SSTR, score 0-3) and the Ki-67 index were assessed. The immunohistochemical findings were compared with the (68)Ga-DOTATATE PET uptake in these tumors using the SUV(max) (standardized uptake value). Both values were compared with the Ki-67 proliferation index. RESULTS: The SUV(max) in NET without SSTR expression was significantly lower compared to those with SSTR expression (p <0.05), even though 3 out of 5 NETs with a score of 0 showed a high uptake of (68)Ga-DOTATATE. The SUV(max) correlated significantly (r=0.40, p <0.05) with the score of immunohistochemical SSTR expression (negative, score 0, moderate, score 1 and high, scores 2 and 3). The Ki-67 index correlated inversely with the SSTR expression score (r=-0.42, p <0.05), but not significantly with the SUV(max) (r=-0.33, p=0.11). CONCLUSION: (68)Ga-DOTATATE uptake was moderately correlated with the results of immunohistochemical SSTR analyses. However, SSTR negative NET may show high uptake of (68)Ga-DOTATATE.
PURPOSE: The immunohistochemical expression of somatostatin receptor (SSTR) subtype 2 was compared to quantitative (68)Ga-DOTATATE PET in neuroendocrine tumors (NET). MATERIAL AND METHODS: In 27 patients suffering from metastatic NET the expression of somatostatin receptors (SSTR, score 0-3) and the Ki-67 index were assessed. The immunohistochemical findings were compared with the (68)Ga-DOTATATE PET uptake in these tumors using the SUV(max) (standardized uptake value). Both values were compared with the Ki-67 proliferation index. RESULTS: The SUV(max) in NET without SSTR expression was significantly lower compared to those with SSTR expression (p <0.05), even though 3 out of 5 NETs with a score of 0 showed a high uptake of (68)Ga-DOTATATE. The SUV(max) correlated significantly (r=0.40, p <0.05) with the score of immunohistochemical SSTR expression (negative, score 0, moderate, score 1 and high, scores 2 and 3). The Ki-67 index correlated inversely with the SSTR expression score (r=-0.42, p <0.05), but not significantly with the SUV(max) (r=-0.33, p=0.11). CONCLUSION: (68)Ga-DOTATATE uptake was moderately correlated with the results of immunohistochemical SSTR analyses. However, SSTR negative NET may show high uptake of (68)Ga-DOTATATE.
Authors: M Papotti; M Bongiovanni; M Volante; E Allìa; S Landolfi; L Helboe; M Schindler; S L Cole; G Bussolati Journal: Virchows Arch Date: 2002-03-23 Impact factor: 4.064
Authors: Wouter A P Breeman; Marion de Jong; Erik de Blois; Bert F Bernard; Mark Konijnenberg; Eric P Krenning Journal: Eur J Nucl Med Mol Imaging Date: 2005-01-18 Impact factor: 9.236
Authors: Michael Gabriel; Clemens Decristoforo; Dorota Kendler; Georg Dobrozemsky; Dirk Heute; Christian Uprimny; Peter Kovacs; Elisabeth Von Guggenberg; Reto Bale; Irene J Virgolini Journal: J Nucl Med Date: 2007-04 Impact factor: 10.057
Authors: James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans Journal: J Clin Oncol Date: 2008-06-20 Impact factor: 44.544
Authors: I Buchmann; M Henze; S Engelbrecht; M Eisenhut; A Runz; M Schäfer; T Schilling; S Haufe; T Herrmann; U Haberkorn Journal: Eur J Nucl Med Mol Imaging Date: 2007-05-23 Impact factor: 9.236
Authors: Daniel Kaemmerer; Maria Athelogou; Amelie Lupp; Isabell Lenhardt; Stefan Schulz; Peter Luisa; Merten Hommann; Vikas Prasad; Gerd Binnig; Richard Paul Baum Journal: Int J Clin Exp Pathol Date: 2014-07-15
Authors: Christine Schmid-Tannwald; Christoph M Schmid-Tannwald; John N Morelli; Ralph Neumann; Alexander R Haug; Nathalie Jansen; Konstantin Nikolaou; Nicolai Schramm; Maximilian F Reiser; Carsten Rist Journal: Eur J Nucl Med Mol Imaging Date: 2013-03-05 Impact factor: 9.236
Authors: Philippe Thuillier; David Bourhis; Jean Philippe Metges; Romain Le Pennec; Karim Amrane; Ulrike Schick; Frédérique Blanc-Beguin; Simon Hennebicq; Pierre-Yves Salaun; Véronique Kerlan; Nicolas Karakatsanis; Ronan Abgral Journal: Sci Rep Date: 2021-03-01 Impact factor: 4.379
Authors: Dominik Berzaczy; Chiara Giraudo; Alexander R Haug; Markus Raderer; Daniela Senn; Georgios Karanikas; Michael Weber; Marius E Mayerhoefer Journal: Clin Nucl Med Date: 2017-09 Impact factor: 7.794
Authors: Susanna Majala; Tiina Vesterinen; Hanna Seppänen; Harri Mustonen; Jari Sundström; Camilla Schalin-Jäntti; Risto Gullichsen; Jukka Schildt; Jukka Kemppainen; Johanna Arola; Saila Kauhanen Journal: Cancers (Basel) Date: 2021-12-29 Impact factor: 6.639
Authors: Fuad Novruzov; Aziz Aliyev; Ming Young S Wan; Rizwan Syed; Elnur Mehdi; Irada Aliyeva; Francesco Giammarile; Jamshed B Bomanji; Irfan Kayani Journal: Eur J Hybrid Imaging Date: 2021-05-24